Data as of November 12, 2026

Deblitane 0.35 mg Tablet

NORETHINDRONE

Brand: DEBLITANE

Acquisition price (NADAC) is as of October 21, 2026. Medicaid reimbursement figures are from 2024, the most recent year in CMS's published claims data. The two are not contemporaneous — treat any comparison as directional, not exact.

Price per fill

NADAC (acquisition)
$5.42/ fill$0.10 / EA
FUL
$4.93/ fill$0.09 / EA
AMP
$2.60/ fill$0.05 / EA
Medicaid FFS
$16.66/ fill
Medicaid MCO
$10.79/ fill

Sources: cms/nadac:price-ladder · cms/ful:generic-ceiling · cms/sdud

What's in the reimbursement

Ingredient cost (55.2 units/fill)$5.42
Dispensing fee & other (state-fixed, not margin)$11.24
Total reimbursed per fill$16.66

The gap above stays roughly flat across drugs regardless of acquisition cost — that's the professional dispensing fee, a fixed per-fill amount the state pays every pharmacy, not a markup.

Medicaid volume backing this card: 11 fee-for-service states, 20 managed-care states.

Full methodology and source columns: /tools/drug-prices/methodology

Sources: acquisition prices from CMS's National Average Drug Acquisition Cost survey, effective 2026-10-28; utilisation from CMS State Drug Utilization Data, 2024; Cost Plus Drugs prices from their published price list. NADAC and SDUD vintages differ. Every number links to how it was calculated. Full methodology